Cleveland Clinic offering Saturday appointments dedicated to contraceptive care

Cleveland Clinic, regularly voted one of the top hospitals in the United States, is now offering Saturday clinics dedicated to contraceptive care for patients. 

The move comes as states continue to make changes regarding abortion care access after the Supreme Court overturned the Constitutional right to abortion established in Roe v. Wade. The Supreme Court also hinted that it will take aim at the right to contraception. 

“Reproductive healthcare decisions are best made between a patient and their healthcare provider,” Tristi Muir, MD, chair of the Obstetrics, Gynecology & Women’s Health Institute at Cleveland Clinic, said in a statement. “It is critical that women and men have immediate access to contraception. As we have seen an increase in the number of vasectomies across the country in the last month, we are working to increase immediate access for women by opening clinics on Saturdays focused on providing contraception.”

The Saturday clinics also come as Democrats in Congress are attempting to codify the right to contraceptive care in law. The Right to Contraception Act, which protects a person’s ability to access contraception and a healthcare provider’s ability to provide it, was approved by the House but blocked by Senate Republicans. Additionally, the U.S. Food and Drug Administration is currently considering an application for the first approval of over-the-counter birth control from HRA Healthcare. 

Cleveland Clinic’s Saturday clinics are available for women ages 14 and older with appointments. The contraception clinics will be open from 8 a.m. to 12 p.m. on Saturdays, starting July 23. Initial locations include: 

  • Avon Pointe Medical Outpatient Center 
  • Beachwood Family Health and Surgery Center 
  • Brunswick Family Health Center 
  • Lakewood Medical Building
  • Main Campus 
  • Stephanie Tubbs Jones Health Center 
  • Willoughby Hills Family Health Center 
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.